Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study

SIMPLE SUMMARY: We performed a retrospective analysis to evaluate the effect of treatment with FOLFIRINOX (FFN) or Nab-paclitaxel plus gemcitabine (GemNab) in patients with locally advanced (LA) pancreatic adenocarcinoma (PDAC). Forty-eight percent of patients treated with FFN became eligible for ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Servetto, Alberto, Santaniello, Antonio, Napolitano, Fabiana, Foschini, Francesca, Marciano, Roberta, Mozzillo, Eleonora, Cascetta, Priscilla, Amato, Anna Rita, Augurio, Maria Rosaria, Maresca, Lucia, De Placido, Pietro, De Placido, Sabino, Formisano, Luigi, Bianco, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508515/
https://www.ncbi.nlm.nih.gov/pubmed/34638422
http://dx.doi.org/10.3390/cancers13194939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508515/
https://www.ncbi.nlm.nih.gov/pubmed/34638422
http://dx.doi.org/10.3390/cancers13194939

Ejemplares similares